Cloud Provider and Systems Integrator Based in France Chooses OcNOS® Over SONiC
SANTA CLARA, Calif., January 17, 2024 – IP Infusion, the market leader in carrier-grade networking software systems, announced today that Madeo Consultant, a systems integrator based in France, has chosen OcNOS as an alternative to Cisco and SONiC for deployment in a Data Center environment. OcNOS serves as a core network switch and public BGP router with transit partners in its Data Center Interconnect use case.
Madeo Consultant is a software provider and Data Center systems integrator, providing cloud networking software as a service to their client base. As such, EVPN VxLAN and BGP features within the OcNOS Data Center and Service Provider software packages were critical needs.
To accommodate increased demand and new services, Madeo Consultant evaluated several network disaggregation strategies, including SONiC and open networking hardware. With IP Infusion's history in networking, OcNOS offered a much more mature market solution. Additionally, SONiC did not provide the BGP features that come standard with the OcNOS Service Provider package.
Madeo Consultant replaced existing Cisco Nexus 3048 and Catalyst 3750 switches with OcNOS to enable EVPN VxLAN and optics, for increased performance. Deployed on hardware from Edgecore et UfiSpace, OcNOS provided an easy transition with an industry-familiar command line interface.
"Disaggregated networking software from IP Infusion with EdgeCore and UfiSpace hardware solved our upgrade needs," said François Defrocourt, Solutions Engineer for Madeo Consultant. "Being able to choose between a variety of hardware vendors allowed us to find a custom-fit solution at an off-the-rack cost. Simple product licensing from IP Infusion made the upgrade experience complete."
"More companies across the world are recognizing the value proposition of disaggregated open networking as a compelling and complete alternative to closed system vendors," said Atsushi Ogata, President and CEO of IP Infusion. "IP Infusion is the proven market leader to provide an end-to-end networking software platform that fully leverages all the benefits of open networking methodologies in a commercial setting."
À propos d'IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers and data centers.With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
À propos d'IP Infusion
IP Infusion est un fournisseur de premier plan de logiciels de réseau ouvert, qui propose OcNOS, un système d'exploitation réseau de niveau opérateur pour les fournisseurs de services, les centres de données et les réseaux de fabric IA. Fort d'une expertise réseau depuis 1999 et de plus de 600 opérateurs dans le monde, IP Infusion permet une infrastructure réseau ouverte, multi-fournisseurs, économique et flexible sur du matériel ouvert validé de partenaires tels qu'Edgecore Networks, UfiSpace et Celestica. IP Infusion est une filiale à 100 % d'ACCESS CO., LTD. (Bourse de Tokyo : 4813).
Contact presse
For press inquiries, analyst briefings, or media materials, please contactez notre équipe or email pr@ipinfusion.com.
Déclarations prospectives
Ce communiqué peut contenir des déclarations prospectives concernant les produits, les technologies et les plans d'IP Infusion. Les déclarations prospectives reposent sur les informations disponibles à la date de publication et comportent des risques et des incertitudes. Les résultats réels peuvent différer. Les plans produit, les fonctionnalités, le calendrier des versions et la disponibilité peuvent changer sans préavis et ne constituent ni un engagement, ni une promesse, ni une obligation juridique. IP Infusion n'assume aucune obligation de mettre à jour ces déclarations prospectives.